Expanded recall for Franck's Compounds

Share this article:

The FDA is notifying all physicians and healthcare organizations of the recall of all sterile products sold by Franck's Compounding Pharmacy since November 2011 due to the possibility of lack of sterility.

In March 19, 2012, FDA received reports of fungal endophthalmitis in patients who were given Brilliant Blue G (BBG), supplied by Franck's Pharmacy, during eye surgeries. In April 20, 2012, FDA received reports of eye infections in patients who were given injections of Franck's drug products containing triamcinolone acetonide during eye surgery.

An active investigation by the CDC and FDA is ongoing at this time. FDA advises that any product received from Franck's since November 2011 not be used.

For more information visit http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm305592.htm.

Share this article:
You must be a registered member of Clinical Advisor to post a comment.

More in Web Exclusives

Diabetes drug lowers CVD risk in type 2 diabetes

Diabetes drug lowers CVD risk in type 2 ...

Fenofibrate improved lipoprotein profile more in women; CVD event reduction similar for men, women.

HPV vaccine safe for teens, provides long-term benefits

HPV vaccine safe for teens, provides long-term benefits

Vaccination-induced anti-HPV response persists through 96 months for all HPV vaccine types.

Discussing direct benefits increases parents' intent to vaccinate

Discussing direct benefits increases parents' intent to vaccinate

Emphasizing only societal benefits of MMR vaccine does not increase intention of parents to vaccinate.